Shots: The US FDA has granted EUA to the BD’s molecular diagnostic test for COVID-19 that provides results in 2-3hrs. The BD SARS-CoV-2 Reagent Kit for BD MAX System has […]readmore
Tags : Emergency Use Authorization
Shots: The US FDA has granted EUA to Terumo BCT’s Spectra Optia Apheresis System combined with Marker Therapeutics’ D2000 Adsorption Cartridge to treat patients aged ≥18yrs. with confirmed COVID-19 and […]readmore
Shots: Abbott has received the US FDA’s EUA for its molecular point-of-care test to detect novel COVID-19 and runs on its ID NOW platform, delivering positive results in just five […]readmore
Shots: Quidel’s Lyra SARS-CoV-2 Assay has received expanded FDA’s EUA to allow testing with three additional thermocyclers: Applied Biosystems 7500 Standard, Roche LightCycler 480, and Qiagen Rotor-Gene Q Under the […]readmore
Shots: The US FDA has issued EUA for Abbott’s molecular test for COVID-19 and will be used on the m2000 RealTime system which is currently available in hospitals and molecular […]readmore
Shots: The US FDA has issued a EUA for Roche’s cobas SARS-CoV-2 test for the qualitative detection of SARS-CoV-2, in nasopharyngeal and oropharyngeal swab samples taken from patients who meet […]readmore
Shots: The US FDA has granted EUA for state public health laboratories to initiate testing of coronavirus utilizing kits developed by the Centers for Disease Control and Prevention (CDC) Under […]readmore